InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Owen Katey Einterz. Director active across 1 company, notably Adaptive Biotechnologies Corp. Cumulatively, 6 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €214k. History available since 26 January 2022. The latest transaction was filed on 26 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Owen Katey Einterz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
9,615 股@ US$26.000.0060% mcap100.0% 占其流量Common StockSEC:0001852578-26-000005:0
15,625 股0Common StockSEC:0001852578-26-000002:0
15,394 股0Common StockSEC:0001062993-25-004806:0
31,328 股0Common StockSEC:0001062993-24-005774:0
14,775 股0Common StockSEC:0001062993-23-006336:0
6,689 股0Common StockSEC:0001209191-22-005494:0
6 条申报中的 6 条
About Owen Katey Einterz
OWEN KATEY EINTERZ is a declarant linked to Adaptive Biotechnologies Corp, where the listed role is Director. He has 6 filings in total, and among the 6 sampled recent filings, the transactions show 0 in buys and 214141 in sells between 2022-01-28 and 2026-08-28, with the modal transaction nature listed as Attribution.
